Please assess the completion status of the following clinical trial:

Trial Title: Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with ADHD only or ADHD and Dyslexia~* At least 10 years old and no more than 16 years old~* IQ score of 80 or more~* Must be able to swallow capsules~Exclusion Criteria:~* Have received treatment within last 30 days with a drug that has not received regulatory approval for any indication at the time of study entry~* Weigh less than 25 kg or greater than 70 kg~* Pregnant or breast feeding~* Documented history of bipolar I or II disorder, or psychosis~* Documented history of autism, Asperger's syndrome or pervasive developmental disorder

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).